Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 18/20 | 0.56 |
| ▸ | CCKAR | P32238 | 3/20 | 0.46 |
| ▸ | CCKBR | P32239 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1505971 | 0.95 | CBLB (0.58) | CBLBCCKARCCKBR | |
| SCHEMBL1505988 | 0.90 | CBLB (0.56) | CBLBCCKARCCKBR | |
| SCHEMBL6519450 | 0.88 | CCKBR (0.56) | CCKARCCKBR | |
| SCHEMBL6519843 | 0.88 | CCKBR (0.56) | CCKARCCKBR | |
| SCHEMBL1505901 | 0.88 | CCKBR (0.56) | CCKARCCKBR | |
| SCHEMBL1506083 | 0.87 | CBLB (0.58) | CBLBCCKARCCKBR | |
| SCHEMBL6521829 | 0.86 | CCKBR (0.53) | CCKARCCKBR | |
| SCHEMBL1506002 | 0.85 | CCKBR (0.52) | CCKARCCKBR | |
| SCHEMBL1506007 | 0.85 | CCKBR (0.52) | CCKARCCKBR | |
| SCHEMBL1506003 | 0.85 | CCKBR (0.52) | CCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011027156-A1 | BENZODIAZEPINE DERIVATIVES FOR TREATING HEPATITIS C INFECTION | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011027156-A1 | BENZODIAZEPINE DERIVATIVES FOR TREATING HEPATITIS C INFECTION | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | WO | disclosed |
| US-20110059043-A1 | CHEMICAL COMPOUNDS | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | US | disclosed |
| US-20110059043-A1 | CHEMICAL COMPOUNDS | ARROW THERAPEUTICS LIMITED (GB) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059043-A1 | CHEMICAL COMPOUNDS | CYP2E1, CNR1, CYP3A5 | CBLB 2079/4885CCKAR 183/4885CCKBR 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.